uniQure N.V. (QURE)

Price$26.45

Value ScoreD

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-11.78%

Price vs S&P 500 (4W)-4.37%

VGM Score47.83

Market Capitalization$1.65B

All Metrics

Book Value / Share (Quarterly)$2.37

P/TBV (Annual)11.69x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-46.73%

Cash Flow / Share (Quarterly)$-2.74

Price vs S&P 500 (YTD)2.37%

Gross Margin (TTM)90.56%

Net Profit Margin (TTM)-1154.42%

EPS (TTM)$-3.51

10-Day Avg Trading Volume1.64M

EPS Excl Extra (TTM)$-3.51

Revenue Growth (5Y)-15.56%

EPS (Annual)$-3.46

ROI (Annual)-27.57%

Gross Margin (Annual)89.53%

Net Profit Margin (5Y Avg)-824.52%

Cash / Share (Quarterly)$9.31

Revenue Growth QoQ (YoY)127.31%

ROA (Last FY)-24.12%

Revenue Growth TTM (YoY)-10.44%

EBITD / Share (TTM)$-3.00

ROE (5Y Avg)-54.23%

Operating Margin (TTM)-1059.74%

Cash Flow / Share (Annual)$-2.86

P/B Ratio11.07x

P/B Ratio (Quarterly)6.85x

Net Income / Employee (Annual)$-900,300

EV / Revenue (TTM)113.09x

Net Interest Coverage (TTM)-9.23x

ROA (TTM)-27.15%

EV / EBITDA (TTM)6.63x

EPS Incl Extra (Annual)$-3.46

Current Ratio (Annual)10.43x

Quick Ratio (Quarterly)10.12x

3-Month Avg Trading Volume2.80M

52-Week Price Return59.24%

Revenue / Employee (TTM)$81,900

Tangible BV / Share (Quarterly)$1.26

P/S Ratio (Annual)102.74x

Asset Turnover (Annual)0.02x

52-Week High$71.50

Operating Margin (5Y Avg)-738.32%

EPS Excl Extra (Annual)$-3.46

CapEx CAGR (5Y)-45.93%

Tangible BV CAGR (5Y)-16.87%

26-Week Price Return-3.85%

Quick Ratio (Annual)10.10x

13-Week Price Return148.36%

Total Debt / Equity (Annual)2.63x

Current Ratio (Quarterly)10.40x

Enterprise Value$2.05B

Revenue / Share Growth (5Y)-19.78%

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-15.47%

Revenue / Employee (Annual)$72,800

Inventory Turnover (Annual)3.05x

Pretax Margin (Annual)-1201.02%

Cash / Share (Annual)$9.99

3-Month Return Std Dev128.91%

Gross Margin (5Y Avg)65.59%

Net Income / Employee (TTM)$-945,100

ROE (Last FY)-100.04%

Net Interest Coverage (Annual)-4.07x

EPS Basic Excl Extra (Annual)$-3.46

P/FCF (TTM)44.46x

Receivables Turnover (TTM)5.95x

Total Debt / Equity (Quarterly)3.56x

EPS Incl Extra (TTM)$-3.51

Receivables Turnover (Annual)2.74x

ROI (TTM)-23.89%

P/S Ratio (TTM)91.41x

Pretax Margin (5Y Avg)-813.47%

Revenue / Share (Annual)$0.28

Tangible BV / Share (Annual)$2.02

Price vs S&P 500 (52W)34.88%

Year-to-Date Return10.53%

5-Day Price Return-6.27%

EPS Normalized (Annual)$-3.46

ROA (5Y Avg)-16.30%

Net Profit Margin (Annual)-1236.00%

Month-to-Date Return-7.29%

Cash Flow / Share (TTM)$-4.60

EBITD / Share (Annual)$-2.97

Operating Margin (Annual)-1151.38%

LT Debt / Equity (Annual)2.63x

ROI (5Y Avg)-18.15%

LT Debt / Equity (Quarterly)3.56x

EPS Basic Excl Extra (TTM)$-3.51

P/TBV (Quarterly)12.88x

P/B Ratio (Annual)7.41x

Inventory Turnover (TTM)3.05x

Pretax Margin (TTM)-1123.34%

Book Value / Share (Annual)$3.19

Price vs S&P 500 (13W)140.10%

Beta0.98x

P/FCF (Annual)6.11x

Revenue / Share (TTM)$0.29

ROE (TTM)-88.99%

52-Week Low$8.73

vGradeD

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.85est. -0.89

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.15

4.05

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
QUREuniQure N.V.	D	C	B	$26.45
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

uniQure NV is a gene therapy company developing treatments for hemophilia, Huntington's disease, and cardiovascular diseases. The company has established a collaboration with Bristol Myers Squibb to advance its cardiovascular gene therapy pipeline.